Research

Unseen Adversaries: The Critical Impact of Airborne Pathogens on Healthcare Safety and Economics

A LifeAire Systems white paper examining the critical impact of airborne pathogens on healthcare safety and economics. The paper reviews the $28.4 billion annual cost of healthcare-associated infections in the United States, the limitations of HEPA filtration as a capture-only strategy that does not neutralize pathogens or eliminate VOCs, and the paradigm shift represented by ASHRAE 241: Control of Infectious Aerosols — which establishes new standards for single-pass pathogen inactivation that LifeAire’s technology meets and surpasses. The paper presents comparative environmental data showing 1,778 cfu/m3 viable biological pathogens and 1,372 ppb chemical contamination in HEPA-only clinical environments versus less than 1 cfu/m3 biological and less than 100 ppb chemical in HEPA plus LifeAire-purified environments. Includes study design details from the St. Luke’s Allentown 12-month hospital study, long-term care outcomes, and ASHRAE publication references. Published by LifeAire Systems, 2026.

Research

LifeAire Systems protected memory support floor over 15 months and delivered 39.6% reduction in facility-acquired infections

A LifeAire Systems case summary presenting key outcomes from the 15-month IRB-approved study of LifeAire’s advanced air purification technology in a memory support long-term care facility. The study compared a LifeAire-protected floor with a HEPA-only control floor in the same facility. Documented outcomes in the LifeAire-protected unit included an 89.1% reduction in airborne pathogens, an 88.9% reduction in surface pathogens, a 39.6% reduction in facility-acquired infections, and a 47% reduction in staff call-outs. The findings demonstrate that continuous air purification delivers measurable improvements in resident health, staff wellbeing, and facility economics in long-term care and memory support environments. The underlying peer-reviewed data was published in The Journals of Gerontology: Series A, 2023. Published by LifeAire Systems, January 2026.

Research

LifeAire Systems protected 14 patient rooms over 12 months and delivered $2.3M in savings

A LifeAire Systems case summary presenting the financial and clinical outcomes from a 12-month air purification study conducted at St. Luke’s University Health Network in Allentown, Pennsylvania. LifeAire’s advanced air purification system was installed in a 14-room medical-surgical unit and compared against a matched HEPA-only control unit across 8,255 patients. Documented outcomes included a 99.99% reduction in viable airborne pathogens, a 97% reduction in surface pathogens, a 39.5% reduction in patient length of stay, a trending reduction in hospital-acquired infections, and $2.3 million in total documented savings in a single year from a system costing less than $125,000 fully installed. The underlying peer-reviewed data was published in the journal Surgery, September 2020. Published by LifeAire Systems, January 2026.

Research

Aire~IRMU™ – VOC Removal Testing Data

Independent third-party testing data documenting the volatile organic compound removal performance of the LifeAire Aire~IRMU In-Room Modular Air Purification Unit. The Aire~IRMU delivers LifeAire’s proven multi-stage purification technology — including molecular media VOC neutralization, UV pathogen kill, and HEPA filtration — in a compact, plug-and-play format requiring no HVAC integration. This testing data validates the VOC remediation capability of the Aire~IRMU for facilities and clinical environments where in-duct systems are not practical, including patient rooms, clinic spaces, senior living environments, and IVF laboratories. Published by LifeAire Systems, January 2026.

Company News

Embracing the Future of Air Quality

Dr. Kathryn C. Worrilow presents recent learnings from operational clinical studies and advocates for more robust indoor air quality standards to be maintained to protect those in acute care settings …